# Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)

> **NCT00458458** · PHASE3 · UNKNOWN · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 112 (estimated)

## Conditions studied

- Endometriosis
- Dysmenorrhea
- Dyspareunia

## Interventions

- **DRUG:** Norethindrone Acetate (NA)
- **DRUG:** GnRH Agonist (Lupron Depot)

## Key facts

- **NCT ID:** NCT00458458
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-08
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2012-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458458, "Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00458458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*